ENST00000455517.6:c.-231G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The ENST00000455517.6(PPARG):c.-231G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0113 in 152,590 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.011 ( 16 hom., cov: 32)
Exomes 𝑓: 0.0074 ( 0 hom. )
Consequence
PPARG
ENST00000455517.6 5_prime_UTR
ENST00000455517.6 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.23
Publications
14 publications found
Genes affected
PPARG (HGNC:9236): (peroxisome proliferator activated receptor gamma) This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]
PPARG Gene-Disease associations (from GenCC):
- PPARG-related familial partial lipodystrophyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0113 (1719/152320) while in subpopulation NFE AF = 0.0164 (1116/68030). AF 95% confidence interval is 0.0156. There are 16 homozygotes in GnomAd4. There are 833 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PPARG | NM_138711.6 | c.-305G>A | upstream_gene_variant | ENST00000651735.1 | NP_619725.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PPARG | ENST00000651735.1 | c.-305G>A | upstream_gene_variant | NM_138711.6 | ENSP00000498313.1 |
Frequencies
GnomAD3 genomes AF: 0.0113 AC: 1721AN: 152202Hom.: 16 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1721
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00741 AC: 2AN: 270Hom.: 0 Cov.: 0 AF XY: 0.00500 AC XY: 1AN XY: 200 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
270
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
200
show subpopulations
African (AFR)
AF:
AC:
0
AN:
8
American (AMR)
AF:
AC:
0
AN:
6
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AF:
AC:
0
AN:
10
South Asian (SAS)
AF:
AC:
0
AN:
4
European-Finnish (FIN)
AF:
AC:
0
AN:
16
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
2
AN:
208
Other (OTH)
AF:
AC:
0
AN:
14
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0113 AC: 1719AN: 152320Hom.: 16 Cov.: 32 AF XY: 0.0112 AC XY: 833AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
1719
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
833
AN XY:
74484
show subpopulations
African (AFR)
AF:
AC:
82
AN:
41572
American (AMR)
AF:
AC:
152
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
91
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5170
South Asian (SAS)
AF:
AC:
18
AN:
4830
European-Finnish (FIN)
AF:
AC:
223
AN:
10620
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1116
AN:
68030
Other (OTH)
AF:
AC:
31
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
94
189
283
378
472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.